|
2022 Conference Publication How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?Tuffaha, Haitham, Arora, Shiksha, Denehy, Linda and Edbrooke, Lara (2022). How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2022 Conference Publication Genetic testing in prostate cancer: a scoping literature reviewEdmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2021 Conference Publication Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancerEdbrooke, Lara, Denehy, Linda, Patrick, Cameron and Tuffaha, Haitham (2021). Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancer. European-Respiratory-Society (ERS) International Congress, Thessaloniki Greece, Sep 26-30, 2021. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2021.OA4227 |
|
2020 Conference Publication Exercise in preventing falls and fractures for men with prostate cancer receiving androgen deprivation therapy: a modelled cost-utility analysisEdmunds, Kim, Scuffham, Paul, Newton, Rob U., Galvao, Daniel A. and Tuffaha, Haitham (2020). Exercise in preventing falls and fractures for men with prostate cancer receiving androgen deprivation therapy: a modelled cost-utility analysis. COSA Annual Scientific Meeting 2020, Virtual meeting, 11-13 November 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13497 |
|
2020 Conference Publication PNS23 Setting health priorities in low-income and middle-income countries in the ASIA-Pacific region: the case of Papua New GuineaTuffaha, H., Radford, K., Chai, A., Rutherford, S., Harris, N. and Scuffham, P. (2020). PNS23 Setting health priorities in low-income and middle-income countries in the ASIA-Pacific region: the case of Papua New Guinea. ISPOR Asia Pacific 2020, Unknown, Unknown. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.vhri.2020.07.442 |
|
2019 Conference Publication Cost-effectiveness of exercise for prostate cancer patients with bone metastases – an exploratory studyEdmunds, Kim, Tuffaha, Haitham, Reeves, Penny, Galvao, Daniel A., Newton, Robert U., Taaffe, Dennis R., Spry, Nigel and Scuffham, Paul (2019). Cost-effectiveness of exercise for prostate cancer patients with bone metastases – an exploratory study. Health services research association of Australia and New Zealand (HSRAANZ), Auckland, New Zealand, 4-6 December 2019. |
|
2019 Conference Publication Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiationEdmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Galvao, Daniel A., Newton, Rob, Spry, Nigel, Denham, James, Taaffe, Dennis R., Joseph, David, Lamb, David S., Chambers, Suzanne K. and Scuffham, Paul (2019). Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation. COSA 46th Annual Scientific Meeting 2019, Adelaide, SA Australia, 12-14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262 |
|
2019 Conference Publication PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologiesTuffaha, H. and Scuffham, P. (2019). PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologies. ISPOR Europe 2019, Copenhagen, Denmark, 2-6 November 2019. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2019.09.292 |
|
2019 Conference Publication Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiationEdmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Galvao, Daniel, Newton, Rob, Spry, Nigel, Denham, James, Taaffe, Dennis R., Joseph, David, Lamb, David S., Chambers, Suzanne K. and Scuffham, Paul (2019). Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, SA, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262 |
|
2019 Conference Publication Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancerTuffaha, Haitham and Scuffham, Paul (2019). Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancer. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262 |
|
2019 Conference Publication PCN349 Value of information analysis guiding the reimbursement decision of olaparib for metastatic breast cancerTuffaha, H. and Scuffham, P. (2019). PCN349 Value of information analysis guiding the reimbursement decision of olaparib for metastatic breast cancer. ISPOR Europe 2019, Copenhagen, Denmark, November 2019. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2019.09.544 |
|
2018 Conference Publication Value For Money, the Overlooked Aspect in Research Funding DecisionsTuffaha, H., El-Saifi, N. and Scuffham, P. (2018). Value For Money, the Overlooked Aspect in Research Funding Decisions. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.413 |
|
2018 Conference Publication Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in AustraliaTuffaha, H. and Scuffham, P. (2018). Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.839 |
|
2018 Conference Publication Can we prospectively assess the value for money of oncology clinical trials?Tuffaha, Haitham, Chambers, Suzanne and Scuffham, Paul (2018). Can we prospectively assess the value for money of oncology clinical trials?. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA Australia, 13–15 November 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13089 |
|
2018 Conference Publication Can technology improve medication adherence in older people with dementia?El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Can technology improve medication adherence in older people with dementia?. 16th International Conference, ICOST 2018, Singapore, 10-12 July, 2018. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-94523-1_1 |
|
2017 Conference Publication INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCERMaraiki, R., Bymes, J., Tuffaha, H. and Hider, M. (2017). INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER. NEW YORK: ELSEVIER SCIENCE INC. |
|
2017 Conference Publication Improving patient access to novel cancer drugs in Australia: are we there yet?Tuffaha, Haitham and Scuffham, Paul (2017). Improving patient access to novel cancer drugs in Australia: are we there yet?. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13-15 November 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2017 Conference Publication International HTA experience with targeted therapy approvals For lung cancerMaraiki, F., Byrnes, J., Tuffaha, H. and Hider, M. (2017). International HTA experience with targeted therapy approvals For lung cancer. ISPOR 20th Annual European Congress, Glasgow, United Kingdom, 4-8 November 2017. New York, NY USA: Elsevier. doi: 10.1016/j.jval.2017.08.335 |
|
2015 Conference Publication Health economic modelling for treatments and services in prostate cancer care: a master model for AustraliaGordon, Louisa, Tuffaha, Haitham, Scuffham, Paul and Lowe, Anthony (2015). Health economic modelling for treatments and services in prostate cancer care: a master model for Australia. 2nd Prostate Cancer World Congress (PCWC), Cairns, QLD, Australia, 17-21 August, 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13196 |
|
2014 Conference Publication COST-EFFECTIVENESS AND VALUE OF INFORMATION ANALYSES OF NUTRITIONAL SUPPORT IN PREVENTING PRESSURE ULCERS IN HIGH RISK HOSPITALISED PATIENTSTuffaha, H. W., Shelley, R., Chaboyer, W., Gordon, L. G. and Scuffham, P. A. (2014). COST-EFFECTIVENESS AND VALUE OF INFORMATION ANALYSES OF NUTRITIONAL SUPPORT IN PREVENTING PRESSURE ULCERS IN HIGH RISK HOSPITALISED PATIENTS. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2014.08.2150 |
